Zydus Lifesciences gains on getting USFDA’s final nod for Ephedrine Sulfate Injection

17 May 2023 Evaluate

Zydus Lifesciences is currently trading at Rs. 517.80, up by 1.75 points or 0.34% from its previous closing of Rs. 516.05 on the BSE.

The scrip opened at Rs. 512.20 and has touched a high and low of Rs. 519.65 and Rs. 512.20 respectively. So far 11066 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 530.70 on 09-May-2023 and a 52 week low of Rs. 329.60 on 20-Jun-2022.

Last one week high and low of the scrip stood at Rs. 528.05 and Rs. 503.35 respectively. The current market cap of the company is Rs. 52406.87 crore.

The promoters holding in the company stood at 74.98%, while Institutions and Non-Institutions held 17.02% and 8.00% respectively.

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Ephedrine Sulfate Injection USP, 50 mg/mL single-dose vials (USRLD: Akovaz Injection).

Ephedrine Sulfate Injection is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. The drug will be manufactured at the group’s injectable manufacturing facility at Jarod, near Vadodara (India). 

Ephedrine Sulfate Injection USP, 50 mg/mL had annual sales of $52 million in the United States (IQVIA MAT Mar. 2023). The group now has 368 approvals and has so far filed over 440 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.


Zydus Lifesciences Share Price

881.10 13.30 (1.53%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×